IL-17, now an important target for treatment in arthritis!

Joint Bone Spine. 2017 May;84(3):247-249. doi: 10.1016/j.jbspin.2016.12.001. Epub 2016 Dec 23.

Author

Pierre Miossec¹

Affiliation

¹ Department of Immunology and Rheumatology, Immunogenomics and inflammation research, Unit EA 4130, University of Lyon, Edouard Herriot Hospital, 5, place d'Arsonval, 69437 Lyon, France. Electronic address: miossec@univ-lyon1.fr.

PMID: 28017822
DOI: 10.1016/j.jbspin.2016.12.001

No abstract available

Keywords: Arthritis; Bone resorption; Cytokines; IL-17; Inflammation.

Publication types

Editorial
Review

MeSH terms

Animals
Antirheumatic Agents / therapeutic use*
Arthritis, Experimental / drug therapy*
Arthritis, Experimental / genetics*
Arthritis, Experimental / physiopathology
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / genetics*
Arthritis, Rheumatoid / physiopathology
Humans
Interleukin-17 / genetics*
Molecular Targeted Therapy / methods
Qualitative Research
Sensitivity and Specificity

Substances

Antirheumatic Agents
Interleukin-17